Roxithromycin for Streptococcal Pharyngitis
Roxithromycin is not an appropriate treatment for streptococcal pharyngitis (strep throat) and should not be used for this indication. The FDA-approved indications for roxithromycin are limited to temporary relief of symptoms related to sensitivity to phenolic compounds—such as occasional headache, diarrhea, minor joint swelling, or fatigue—and have nothing to do with bacterial infections. 1
Why Roxithromycin Is Inappropriate
- The FDA labeling for roxithromycin does not include any antimicrobial indication; it is marketed solely for symptomatic relief of phenolic compound sensitivity, administered as sublingual drops (10 drops up to 3 times daily). 1
- Clinical trial data demonstrate poor bacteriologic efficacy: In a prospective study comparing roxithromycin 150 mg twice daily for 10 days versus erythromycin ethylsuccinate in adults with streptococcal pharyngitis, roxithromycin achieved only 33% microbiological cure compared to 90% with erythromycin, making it unacceptable as an alternative agent for acute streptococcal pharyngitis. 2
- Another trial confirmed inferior eradication rates: Roxithromycin 300 mg daily was significantly less effective than erythromycin 500 mg four times daily in eradicating Streptococcus pyogenes, despite comparable clinical symptom relief. 3
- Persistence of Group A Streptococcus was common: In a comparative study, S. pyogenes persisted at the end of treatment in 20% of roxithromycin-treated patients versus 12% with azithromycin, and three episodes of reinfection occurred in the roxithromycin group. 4
Guideline-Recommended First-Line Therapy
- Penicillin V or amoxicillin remains the drug of choice for streptococcal pharyngitis in patients without penicillin allergy, due to proven efficacy, zero documented resistance worldwide, narrow antimicrobial spectrum, excellent safety, and low cost. 5, 6
- Amoxicillin dosing: 50 mg/kg once daily (maximum 1000 mg) or 25 mg/kg twice daily (maximum 500 mg per dose) for a full 10-day course in children; 500 mg twice daily for 10 days in adults. 5, 6
- Penicillin V dosing: 250 mg 2–3 times daily (or 500 mg twice daily) for 10 days in adults and children ≥27 kg; 250 mg 2–3 times daily for children <27 kg. 5
Alternatives for Penicillin-Allergic Patients
Non-Immediate (Delayed) Penicillin Allergy
- First-generation cephalosporins (e.g., cephalexin 500 mg twice daily for 10 days in adults; 20 mg/kg twice daily, max 500 mg per dose, in children) are preferred, with only ~0.1% cross-reactivity risk and essentially zero resistance among Group A Streptococcus. 5
Immediate/Anaphylactic Penicillin Allergy
- Clindamycin is the optimal choice (300 mg three times daily for 10 days in adults; 7 mg/kg three times daily, max 300 mg per dose, in children), with only ~1% resistance in the United States and superior eradication even in chronic carriers. 5
- Azithromycin (500 mg once daily for 5 days in adults; 12 mg/kg once daily, max 500 mg, for 5 days in children) is an acceptable alternative, though macrolide resistance ranges from 5–8% in the United States. 5
Critical Treatment Duration
- A full 10-day course is mandatory for all antibiotics except azithromycin to achieve maximal pharyngeal eradication of Group A Streptococcus and prevent acute rheumatic fever; shortening the course by even 2–3 days markedly increases treatment failure and rheumatic fever risk. 5, 6
- Azithromycin requires only 5 days due to its prolonged tissue half-life. 5, 6
Common Pitfalls to Avoid
- Do not prescribe roxithromycin for streptococcal pharyngitis; it lacks FDA approval for this indication and demonstrates poor bacteriologic cure rates (33%) compared to standard therapy. 2
- Do not use macrolides (including roxithromycin) as first-line therapy when penicillin or amoxicillin can be used; reserve them strictly for patients with documented immediate penicillin allergy. 5
- Do not shorten the antibiotic course below 10 days (except azithromycin's 5-day regimen), as this dramatically increases treatment failure and rheumatic fever risk. 5, 6